Evidence map›Paper›PMID 36349154›Full record

ReviewRSC advances2022

Electrochemical creatinine detection for advanced point-of-care sensing devices: a review.

Carlos Luis Gonzalez-Gallardo, Noé Arjona, Lorena Álvarez-Contreras, Minerva Guerra-Balcázar

Erratum issuedAbstract readReview
In one paragraph

Review in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Carlos Luis Gonzalez-GallardoFacultad de Ingeniería, División de Investigación y Posgrado, Universidad Autónoma de Querétaro Querétaro C. P. 76010 Mexico minbalca@yahoo.com.mx.ORCID https://orcid.org/0000-0002-0659-0350
Noé ArjonaCentro de Investigación y Desarrollo Tecnológico en Electroquímica S. C. Sanfandila, Pedro Escobedo Querétaro C. P. 76703 Mexico.ORCID https://orcid.org/0000-0002-4136-4738
Lorena Álvarez-ContrerasCentro de Investigación en Materiales Avanzados S. C. Complejo Industrial Chihuahua Chihuahua C. P. 31136 Mexico lorena.alvarez@cimav.edu.mx.ORCID https://orcid.org/0000-0002-0504-4112
Minerva Guerra-BalcázarFacultad de Ingeniería, División de Investigación y Posgrado, Universidad Autónoma de Querétaro Querétaro C. P. 76010 Mexico minbalca@yahoo.com.mx.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Creatinine is an amino acid derived from creatine catabolism at different steps of the body's organs, and its detection is significant because levels out of normal values are linked to some diseases like kidney failure. Normal concentration levels of creatinine in blood are from 45 to 110 μM, while in urine, typical concentrations range between 3.3 to 27 mM, and in saliva from 8.8 and 26.5 μM. Nowadays, the creatinine detection is carried through different spectroscopic-colorimetric methods; however, the resulting values present errors due to high interferences, delayed analysis, and poor stability. Electrochemical sensors have been an alternative to creatinine detection, and the electrochemical methods have been adapted to detect in enzymatic and non-enzymatic sensors, the latter being more relevant in recent years. Nanomaterials have made creatinine sensors more stable, sensitive, and selective. This review presents recent advances in creatinine electrochemical sensors for advances in point-of-care (POC) sensing devices, comprising both a materials point of view and prototypes for advanced sensing. The effect of the metal, particle size, shape and other morphological and electronic characteristics of nanomaterials are discussed in terms of their impact on the effective detection of creatinine. In addition, the application of nanomaterials in POC devices is revised pointing to practical applications and looking for more straightforward and less expensive devices to manufacture.

Identifiers

PMID36349154
PMCPMC9606732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.